Search results - 15 results

In vitro activity of amphotericin B, fluconazole and voriconazole against 162 Cryptococcus neoformans isolates from Africa and Cambodia36727

Cryptococcus de Developing Countries Diagnosis differences drug effects Drug Resistance,Fungal epidemiology ET evidence Female Fluconazole France Humans i im IS isolation & purification journal Less Male ...

Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidence.

Opportunistic Infections Developing Countries HIV Infections Humans Mycobacterium tuberculosis sputum Tuberculosis, Pulmonary Abstract: Sputum smear examination for acid-fast bacilli (AFB) can diagnose up to ...

Management of co-infection with HIV and TB.

Antiretroviral Therapy, Highly Active Antitubercular Agents Developing Countries Humans Tuberculosis Health Topics:  Antimicrobial resistance (AMR) Category:  A1 FOS Classification:  3.03 Health sciences ...

The effect of a cluster-randomized controlled trial on lifestyle behaviors among families at risk for developing type 2 diabetes across Europe: the Feel4Diabetes-study.

behaviors among European families at risk for developing type 2 diabetes. Intervention effects on self-reported physical activity, sedentary behavior and eating behaviors were investigated across and within ...

From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis.

animals in many developing countries. The long duration and high cost of treatment of human brucellosis reduces the efficacy of the therapy. There is no human vaccine for brucellosis and the occurrence of ...

QR code

QR code for this page URL